N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C119H135F15N22O10 — CID 165020170

IUPACN-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)c1
InChIInChI=1S/C25H29F3N4O2.C24H28F3N5O.C24H27F3N4O3.C23H26F3N5O2.C23H25F3N4O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-22(2,33)16-12-18-14(13-31(30-18)15-7-9-23(3,34)10-8-15)11-19(16)29-21(32)17-5-4-6-20(28-17)24(25,26)27;1-22(33)9-7-15(8-10-22)31-13-14-11-18(19(30(2)3)12-17(14)29-31)28-21(32)16-5-4-6-20(27-16)23(24,25)26;1-22(2,3)15-7-17(8-15)30-12-14-6-19(20(32-4)9-18(14)29-30)28-21(31)13-5-16(11-27-10-13)23(24,25)26/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);4-6,11-13,15,33-34H,7-10H2,1-3H3,(H,29,32);4-6,11-13,15,33H,7-10H2,1-3H3,(H,28,32);5-6,9-12,15,17H,7-8H2,1-4H3,(H,28,31)
InChIKeyLASADBTYGYYRQS-UHFFFAOYSA-N
MW2318.50 g/mol
LogP27.12
Rot. Bonds20

About N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 165020170) has the molecular formula C119H135F15N22O10 and a molecular weight of 2318.50 g/mol. Its IUPAC name is N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID165020170
Molecular FormulaC119H135F15N22O10
Molecular Weight2318.50 g/mol
Exact Mass2317.05
IUPAC NameN-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)c1
InChIInChI=1S/C25H29F3N4O2.C24H28F3N5O.C24H27F3N4O3.C23H26F3N5O2.C23H25F3N4O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-22(2,33)16-12-18-14(13-31(30-18)15-7-9-23(3,34)10-8-15)11-19(16)29-21(32)17-5-4-6-20(28-17)24(25,26)27;1-22(33)9-7-15(8-10-22)31-13-14-11-18(19(30(2)3)12-17(14)29-31)28-21(32)16-5-4-6-20(27-16)23(24,25)26;1-22(2,3)15-7-17(8-15)30-12-14-6-19(20(32-4)9-18(14)29-30)28-21(31)13-5-16(11-27-10-13)23(24,25)26/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);4-6,11-13,15,33-34H,7-10H2,1-3H3,(H,29,32);4-6,11-13,15,33H,7-10H2,1-3H3,(H,28,32);5-6,9-12,15,17H,7-8H2,1-4H3,(H,28,31)
InChIKeyLASADBTYGYYRQS-UHFFFAOYSA-N
XLogP27.12
TPSA395.68 Ų
H-Bond Donors9
H-Bond Acceptors27
Rotatable Bonds20
Heavy Atoms166
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002318.50
LogP ≤ 527.12
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1027

Analyze N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-[4-[[2-[[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155437934
US20240423977, Example I-20
CID 175664369
US20240423977, Example I-25
CID 175664371
US20240423977, Example I-32
CID 175664378
US20240423977, Example I-33
CID 175664379
US20240423977, Example I-35
CID 175664381
CID 155437705
CID 155437705
N-[2-[4-[[2-[[[2-[(3S)-2,6-dioxopiperidin-3-yl]-1,3-dioxoisoindol-4-yl]amino]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155437842
6-(1,1-difluoroethyl)-N-[2-[4-[[2-[2-[[2-[(3S)-2,6-dioxopiperidin-3-yl]-1,3-dioxoisoindol-4-yl]amino]ethyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]pyridine-2-carboxamide
CID 155438141
N-[2-[4-[[2-[[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxoisoindol-4-yl]amino]methyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438730
6-(1,1-difluoroethyl)-N-[2-[4-[[2-[2-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxoisoindol-4-yl]amino]ethyl]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]pyridine-2-carboxamide
CID 155438861
N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155448663

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 165020170) is N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CC1(O)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)c1.
What is the InChIKey of N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is LASADBTYGYYRQS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29F3N4O2.C24H28F3N5O.C24H27F3N4O3.C23H26F3N5O2.C23H25F3N4O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-22(2,33)16-12-18-14(13-31(30-18)15-7-9-23(3,34)10-8-15)11-19(16)29-21(32)17-5-4-6-20(28-17)24(25,26)27;1-22(33)9-7-15(8-10-22)31-13-14-11-18(19(30(2)3)12-17(14)29-31)28-21(32)16-5-4-6-20(27-16)23(24,25)26;1-22(2,3)15-7-17(8-15)30-12-14-6-19(20(32-4)9-18(14)29-30)28-21(31)13-5-16(11-27-10-13)23(24,25)26/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);4-6,11-13,15,33-34H,7-10H2,1-3H3,(H,29,32);4-6,11-13,15,33H,7-10H2,1-3H3,(H,28,32);5-6,9-12,15,17H,7-8H2,1-4H3,(H,28,31).
What are the key properties of N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2318.50 g/mol, XLogP of 27.12, 20 rotatable bonds, 9 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 165020170), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).